The FTC’s interim report, titled “Pharmacy Benefit Managers: Ten Powerful Middlemen Inflating Drug Costs and Squeezing Main ...
The FTC opened an investigation in June 2022 into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime ...
Federal regulators plan to sue the top three pharmacy-benefit managers over how they negotiate prices for drugs, including ...
PBMs and brand drug manufacturers sometimes negotiate drug rebates that limit access to lower-cost generic alternatives, FTC ...
The news comes just one day after the FTC announced it had completed a two-year investigation into the industry. Pharmacy ...
What that memo described, according to a new report from the Federal Trade Commission, is standard operating procedure among ...
Pharmacy benefit managers (PBMs) wield enormous power on the accessibility and affordability of prescription drugs, and a ...
Eli Lilly inked a $140 million upfront deal with Radionetics Oncology. Merit Medical will acquire EndoGastric Solutions for ...
The U.S. District Court for the District of New Jersey’s recent decision in Teva v. Amneal 1 elaborates on the standard ... and method of use patents. 17 Amneal and the FTC contended the patents at ...
National Heat Protections Proposed: Following California's lead, the Biden administration on Tuesday announced that it will advance a proposed rule to protect indoor and outdoor workers from high ...
A Georgia chiropractor admitted to nearly $15 million in healthcare fraud related to a kickback scheme involving durable ...
The Federal Trade Commission has ordered Teva Pharmaceuticals to provide internal documents about its patents on asthma and COPD inhalers. The move is part of a larger dispute over minor tweaks made ...